Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients.

Schwartz, Thomas; Jensenius, Mogens; Blomberg, Bjørn; Fladeby, Cathrine; Mæland, Arild; Pettersen, Frank O

Schwartz, Thomas; Jensenius, Mogens; Blomberg, Bjørn; Fladeby, Cathrine; Mæland, Arild; Pettersen, Frank O.

Afiliación

Schwartz T; 1Department of Infectious Diseases, Ullevål, Oslo University Hospital, Oslo, Norway.
Jensenius M; Department of Medical Microbiology, Vestre Viken, Drammen, Norway.
Blomberg B; 1Department of Infectious Diseases, Ullevål, Oslo University Hospital, Oslo, Norway.
Fladeby C; 3Norwegian National Advisory Unit on Tropical Infectious Diseases. Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Mæland A; 4Department of Clinical Science, University of Bergen, Bergen, Norway.
Pettersen FO; 5Department of Microbiology, Ullevål, Oslo University Hospital, Oslo, Norway.

Trop Dis Travel Med Vaccines ; 5: 16, 2019.

Article en En | MEDLINE | ID: mdl-31463070

Palabras clave

Autoimmune disease; Immunosuppression; Leishmaniasis; Methotrexate; Rheumatic disease; Travel medicine; Tumor necrosis factor alpha inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Trop Dis Travel Med Vaccines Año: 2019 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google